🇩🇪 Marstacimab in Germany

Marstacimab (marstacimab) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Hympavzi
  • Status: approved

Marstacimab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in Germany

Frequently asked questions

Is Marstacimab approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for Marstacimab in Germany?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.